- Primary T-cell Lymphoma of the Thyroid Associated with Hashimoto's Thyroiditis, Histologically Mimicking MALT-Lymphoma
-
Kim NR, Ko YH, Lee YD
- KMID: 1778048
- J Korean Med Sci.
- 2010 Mar;25(3):481-484.
- doi: 10.3346/jkms.2010.25.3.481
Most of thyroid lymphomas are B-lineage, and T-cell lymphomas are rare. Here, we report a case of primary thyroid T-cell lymphoma associated with Hashimoto's thyroiditis. A 48-yr-old woman presented with... -
- CITED
-
- Close
- SHARE
-
- Close
- Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination
-
Kim A, Noh YW, Kim KD, Jang YS, Choe YK, Lim JS
- KMID: 1123764
- Exp Mol Med.
- 2004 Oct;36(5):428-443.
Immunization with dendritic cells (DCs) pulsed with tumor antigen can activate tumor-specific cytotoxic T lymphocytes (CTL), which is responsible for tumor protection and regression. In this study, we examined whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy
-
Kim S, Chung HW, Kong HY, Lim JB
- KMID: 2374187
- Yonsei Med J.
- 2017 Jan;58(1):43-50.
- doi: 10.3349/ymj.2017.58.1.43
PURPOSE: To identify new immunogenic HLA-A*33;03-restricted epitopes from the human papillomavirus (HPV) 16 E7 protein for immunotherapy against cervical cancer. MATERIALS AND METHODS: We synthesized fourteen overlapping 15-amino acid peptides and... -
- CITED
-
- Close
- SHARE
-
- Close
- Active Immunization Using Dendritic Cells Mixed With Tumor Cells Inhibits The Growth Of Lymphomas
-
Park J, Suh C, Yang J, Park JS, Park KU, Min YJ, Kim HJ, Kim YH, Kim SH
- KMID: 2157653
- J Korean Med Sci.
- 2003 Jun;18(3):372-380.
- doi: 10.3346/jkms.2003.18.3.372
Dendritic cells (DCs) are potent antigen-presenting cells for the induction and activation of cytotoxic T lymphocytes. We tested whether bone marrow derived DCs are capable of inducing protective immunity against... -
- CITED
-
- Close
- SHARE
-
- Close
- Antitumor immunity induced by tumor cells engineered to express a membrane-bound form of IL-2
-
Chang MR, Lee WH, Choi JW, Park SO, Paik SG, Kim YS
- KMID: 1056237
- Exp Mol Med.
- 2005 Jun;37(3):240-249.
Transduction of cytokine gene into tumor cells is a promising method of tumor therapy, but the value is limited by accompanying side effects. To focus antitumor immune response to tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Glioma Stem Cell-Targeted Dendritic Cells as a Tumor Vaccine Against Malignant Glioma
-
Ji B, Chen Q, Liu B, Wu L, Tian D, Guo Z, Yi W
- KMID: 1776923
- Yonsei Med J.
- 2013 Jan;54(1):92-100.
- doi: 10.3349/ymj.2013.54.1.92
PURPOSE: Cancer stem cells have recently been thought to be closely related to tumor development and reoccurrence. It may be a promising way to cure malignant glioma by using glioma... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B
-
Shin SY, Jeong SH, Sung PS, Lee J, Kim HJ, Lee HW, Shin EC
- KMID: 2374085
- Yonsei Med J.
- 2016 May;57(3):652-657.
- doi: 10.3349/ymj.2016.57.3.652
PURPOSE: Acute hepatitis A (AHA) and acute hepatitis B (AHB) are caused by an acute infection of the hepatitis A virus and the hepatitis B virus, respectively. In both AHA... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Dendritic Cells Matured Early with OK-432 (Picibanil(R)), Prostaglandin E2, and Interferon-alpha as a Vaccine for a Hormone Refractory Prostate Cancer Cell Line
-
Yoo C, Do HA, Jeong IG, Park H, Hwang JJ, Hong JH, Cho JS, Choo MS, Ahn H, Kim CS
- KMID: 1785906
- J Korean Med Sci.
- 2010 Sep;25(9):1284-1290.
- doi: 10.3346/jkms.2010.25.9.1284
Dendritic cells (DCs) are potent antigen-presenting cells. OK432 (Picibanil(R)) was introduced as a potent stimulator of DC maturation in combination with prostaglandin-E2 and interferon-alpha. We compared the efficacy of a... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-tumor immunostimulatory effect of heat-killed tumor cells
-
Yoon TJ, Kim JY, Kim H, Hong C, Lee H, Lee CK, Lee KH, Hong S, Park SH
- KMID: 1103596
- Exp Mol Med.
- 2008 Feb;40(1):130-144.
- doi: 10.3858/emm.2008.40.1.130
As a part of our ongoing search for a safe and efficient anti-tumor vaccine, we attempted to determine whether the molecular nature of certain tumor antigens would influence immune responses... -
- CITED
-
- Close
- SHARE
-
- Close
